Addressing challenges in low-income and middle-income countries through novel radiotherapy research opportunities

May Abdel-Wahab; C. Norman Coleman; Jesper Grau Eriksen; Peter Lee; Ryan Kraus; Ekaterina Harsdorf; Becky Lee; Adam Dicker; Ezra Hahn; Jai Prakash Agarwal; Pataje G.S. Prasanna; Michael MacManus; Paul Keall; Nina A. Mayr; Barbara Alicja Jereczek-Fossa; Francesco Giammarile; In Ah Kim; Ajay Aggarwal; Grant Lewison; Jiade J. Lu; Douglas Guedes de Castro; Feng Ming (Spring) Kong; Haidy Afifi; Hamish Sharp; Verna Vanderpuye; Tajudeen Olasinde; Fadi Atrash; Luc Goethals; Benjamin W. Corn

doi:10.1016/S1470-2045(24)00038-X

Addressing challenges in low-income and middle-income countries through novel radiotherapy research opportunities

May Abdel-Wahab^*, C. Norman Coleman, Jesper Grau Eriksen, Peter Lee, Ryan Kraus, Ekaterina Harsdorf, Becky Lee, Adam Dicker, Ezra Hahn, Jai Prakash Agarwal, Pataje G.S. Prasanna, Michael MacManus, Paul Keall, Nina A. Mayr, Barbara Alicja Jereczek-Fossa, Francesco Giammarile, In Ah Kim, Ajay Aggarwal, Grant Lewison, Jiade J. LuDouglas Guedes de Castro, Feng Ming (Spring) Kong, Haidy Afifi, Hamish Sharp, Verna Vanderpuye, Tajudeen Olasinde, Fadi Atrash, Luc Goethals, Benjamin W. Corn

^*Corresponding author for this work

Department of Clinical Medicine - The Department of Oncology

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Review › Research › peer-review

Abstract

Although radiotherapy continues to evolve as a mainstay of the oncological armamentarium, research and innovation in radiotherapy in low-income and middle-income countries (LMICs) faces challenges. This third Series paper examines the current state of LMIC radiotherapy research and provides new data from a 2022 survey undertaken by the International Atomic Energy Agency and new data on funding. In the context of LMIC-related challenges and impediments, we explore several developments and advances—such as deep phenotyping, real-time targeting, and artificial intelligence—to flag specific opportunities with applicability and relevance for resource-constrained settings. Given the pressing nature of cancer in LMICs, we also highlight some best practices and address the broader need to develop the research workforce of the future. This Series paper thereby serves as a resource for radiation professionals.

Original language	English
Journal	The Lancet Oncology
Volume	25
Issue	6
Pages (from-to)	e270-e280
Number of pages	11
ISSN	1470-2045
DOIs	https://doi.org/10.1016/S1470-2045(24)00038-X
Publication status	Published - Jun 2024

Access to Document

10.1016/S1470-2045(24)00038-X

Cite this

Abdel-Wahab, M., Coleman, C. N., Eriksen, J. G., Lee, P., Kraus, R., Harsdorf, E., Lee, B., Dicker, A., Hahn, E., Agarwal, J. P., Prasanna, P. G. S., MacManus, M., Keall, P., Mayr, N. A., Jereczek-Fossa, B. A., Giammarile, F., Kim, I. A., Aggarwal, A., Lewison, G., ... Corn, B. W. (2024). Addressing challenges in low-income and middle-income countries through novel radiotherapy research opportunities. The Lancet Oncology, 25(6), e270-e280. https://doi.org/10.1016/S1470-2045(24)00038-X

@article{b9494d642bc74b8293add3a4765d002a,

title = "Addressing challenges in low-income and middle-income countries through novel radiotherapy research opportunities",

abstract = "Although radiotherapy continues to evolve as a mainstay of the oncological armamentarium, research and innovation in radiotherapy in low-income and middle-income countries (LMICs) faces challenges. This third Series paper examines the current state of LMIC radiotherapy research and provides new data from a 2022 survey undertaken by the International Atomic Energy Agency and new data on funding. In the context of LMIC-related challenges and impediments, we explore several developments and advances—such as deep phenotyping, real-time targeting, and artificial intelligence—to flag specific opportunities with applicability and relevance for resource-constrained settings. Given the pressing nature of cancer in LMICs, we also highlight some best practices and address the broader need to develop the research workforce of the future. This Series paper thereby serves as a resource for radiation professionals.",

author = "May Abdel-Wahab and Coleman, {C. Norman} and Eriksen, {Jesper Grau} and Peter Lee and Ryan Kraus and Ekaterina Harsdorf and Becky Lee and Adam Dicker and Ezra Hahn and Agarwal, {Jai Prakash} and Prasanna, {Pataje G.S.} and Michael MacManus and Paul Keall and Mayr, {Nina A.} and Jereczek-Fossa, {Barbara Alicja} and Francesco Giammarile and Kim, {In Ah} and Ajay Aggarwal and Grant Lewison and Lu, {Jiade J.} and {Guedes de Castro}, Douglas and Kong, {Feng Ming (Spring)} and Haidy Afifi and Hamish Sharp and Verna Vanderpuye and Tajudeen Olasinde and Fadi Atrash and Luc Goethals and Corn, {Benjamin W.}",

note = "Publisher Copyright: {\textcopyright} 2024 Elsevier Ltd",

year = "2024",

month = jun,

doi = "10.1016/S1470-2045(24)00038-X",

language = "English",

volume = "25",

pages = "e270--e280",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "TheLancet Publishing Group",

number = "6",

}

Abdel-Wahab, M, Coleman, CN, Eriksen, JG, Lee, P, Kraus, R, Harsdorf, E, Lee, B, Dicker, A, Hahn, E, Agarwal, JP, Prasanna, PGS, MacManus, M, Keall, P, Mayr, NA, Jereczek-Fossa, BA, Giammarile, F, Kim, IA, Aggarwal, A, Lewison, G, Lu, JJ, Guedes de Castro, D, Kong, FM, Afifi, H, Sharp, H, Vanderpuye, V, Olasinde, T, Atrash, F, Goethals, L & Corn, BW 2024, 'Addressing challenges in low-income and middle-income countries through novel radiotherapy research opportunities', The Lancet Oncology, vol. 25, no. 6, pp. e270-e280. https://doi.org/10.1016/S1470-2045(24)00038-X

Addressing challenges in low-income and middle-income countries through novel radiotherapy research opportunities. / Abdel-Wahab, May; Coleman, C. Norman; Eriksen, Jesper Grau et al.
In: The Lancet Oncology, Vol. 25, No. 6, 06.2024, p. e270-e280.

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Review › Research › peer-review

TY - JOUR

T1 - Addressing challenges in low-income and middle-income countries through novel radiotherapy research opportunities

AU - Abdel-Wahab, May

AU - Coleman, C. Norman

AU - Eriksen, Jesper Grau

AU - Lee, Peter

AU - Kraus, Ryan

AU - Harsdorf, Ekaterina

AU - Lee, Becky

AU - Dicker, Adam

AU - Hahn, Ezra

AU - Agarwal, Jai Prakash

AU - Prasanna, Pataje G.S.

AU - MacManus, Michael

AU - Keall, Paul

AU - Mayr, Nina A.

AU - Jereczek-Fossa, Barbara Alicja

AU - Giammarile, Francesco

AU - Kim, In Ah

AU - Aggarwal, Ajay

AU - Lewison, Grant

AU - Lu, Jiade J.

AU - Guedes de Castro, Douglas

AU - Kong, Feng Ming (Spring)

AU - Afifi, Haidy

AU - Sharp, Hamish

AU - Vanderpuye, Verna

AU - Olasinde, Tajudeen

AU - Atrash, Fadi

AU - Goethals, Luc

AU - Corn, Benjamin W.

PY - 2024/6

Y1 - 2024/6

N2 - Although radiotherapy continues to evolve as a mainstay of the oncological armamentarium, research and innovation in radiotherapy in low-income and middle-income countries (LMICs) faces challenges. This third Series paper examines the current state of LMIC radiotherapy research and provides new data from a 2022 survey undertaken by the International Atomic Energy Agency and new data on funding. In the context of LMIC-related challenges and impediments, we explore several developments and advances—such as deep phenotyping, real-time targeting, and artificial intelligence—to flag specific opportunities with applicability and relevance for resource-constrained settings. Given the pressing nature of cancer in LMICs, we also highlight some best practices and address the broader need to develop the research workforce of the future. This Series paper thereby serves as a resource for radiation professionals.

AB - Although radiotherapy continues to evolve as a mainstay of the oncological armamentarium, research and innovation in radiotherapy in low-income and middle-income countries (LMICs) faces challenges. This third Series paper examines the current state of LMIC radiotherapy research and provides new data from a 2022 survey undertaken by the International Atomic Energy Agency and new data on funding. In the context of LMIC-related challenges and impediments, we explore several developments and advances—such as deep phenotyping, real-time targeting, and artificial intelligence—to flag specific opportunities with applicability and relevance for resource-constrained settings. Given the pressing nature of cancer in LMICs, we also highlight some best practices and address the broader need to develop the research workforce of the future. This Series paper thereby serves as a resource for radiation professionals.

UR - http://www.scopus.com/inward/record.url?scp=85194037565&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(24)00038-X

DO - 10.1016/S1470-2045(24)00038-X

M3 - Review

C2 - 38821101

AN - SCOPUS:85194037565

SN - 1470-2045

VL - 25

SP - e270-e280

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 6

ER -

Addressing challenges in low-income and middle-income countries through novel radiotherapy research opportunities

Abstract

Access to Document

Other files and links

Fingerprint

Cite this